Oral Board Review Course (2020)

Dallas, TX US
January 17, 2020 to January 18, 2020

This course is SOLD OUT! For additional exam prep resources, check out the Oral Board Study Guide App.  To join the wait list, contact education@AUAnet.org.


The purpose of AUA Oral Board Review Course is to prepare attendees for the ABU Certifying Examination (Part II). The course will provide attendees with valuable practice and preparation skills for taking the urology oral board exam in Dallas. This is a highly interactive course that emulates the oral board exam given by the American Board of Urology. Attendees will participate in two-75 minute mock oral exam sessions as well as case role play practice sessions, a guidelines review, a dinner session with our expert faculty who will offer tips and tricks for taking the exam, and more! In addition to experiencing mock oral exams that are realistic, attendees will also receive guidance from expert oral examiners and the opportunity to refine thought process, communication skills and decision-making ability.

 

Attendees must choose the Friday OR Saturday Program when registering but not both. 

Please select which group you wish to be in at the time of registration.  The selection is a first come basis and will be completed once you register. Your group selection determines your arrival and departure time. If your arrival time is delayed, you will not be able to reschedule your mock oral examination.


AUA Members save 20%! For more information on membership benefits, visit www.AUAnet.org/Join

Register on or before December 6th to save 25%!

Registration Fees
 

 

Live Course 

Early Bird Registration
(on or before December 6, 2019)

Live Course

Standard Registration
(On or after December 7, 2019)

Oral Board Study Guide App*

AUA Member$1495$1795$150
AUA Non-Member$1865$2245

*Discounted Pricing on the Oral Board Study Guide App Only For Course Registrants (Regularly $300) 

 

Target Audience

  • Urologist

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Practice the format of the oral board exam
  2. Utilize interpersonal and communication skills that result in effective information exchange
  3. Demonstrate skills to effectively manage anxiety and "exam nerves"
  4. Develop greater self-awareness and confidence in oral examination
  5. Apply the experience gained in the AUA Oral Board Review Course to better prepare them for the oral board exam
    Course summary
    Course opens: 
    06/27/2019
    Course expires: 
    01/18/2023
    Event starts: 
    01/17/2020 - 7:00am EST
    Event ends: 
    01/18/2020 - 5:00pm EST
    Price:
    $2,245.00
    Rating: 
    0

    Friday Program Includes:

    • Early Registration available Thursday
    • 2 –75 Minute Mock Exams
    • Individualized Feedback from Expert Examiners
    • Role Play Session with Take Home Cases
    • Additional Preparation Sessions, Case Discussions with Experts, Guidelines Review, etc.
    • Lunch Included
    • Dinner and General Session for all Course Attendees with the Faculty including Tips & Tricks 
    • Special Discount Pricing of the Oral Board Study Guide APP for Course Attendees

    Thursday, January 16, 2020

    7:00-8:30 p.m.

    Groups 1-3  Early Registration

    Friday, January 17, 2020

    7:00-8:00 a.m.

    Registration

    8:15 a.m.-12:30 p.m.

    Morning Sessions

    12:30 - 1:15 p.m.

    Break

    1:15-5:45 p.m.

    Afternoon Sessions

    6:45-8:15 p.m.

    Dinner and General Session for all Attendees with Faculty

    Tips &Tricks

    8:15 p.m.

    Course Adjourns

    OR

    Saturday Program* Includes:

    *Begins with Dinner and General Session with the Faculty on Friday at 6:45 p.m.

    • Early Registration available Friday
    • 2 –75 Minute Mock Exams
    • Individualized Feedback from Expert Examiners
    • Role Play Session with Take Home Cases
    • Additional Preparation Sessions, Case Discussions with Experts, Guidelines Review, etc.
    • Lunch Included
    • Dinner and General Session for all Course Attendees with the Faculty including Tips & Tricks 
    • Special Discount Pricing of the Oral Board Study Guide APP for Course Attendees

    Friday, January 17, 2020

    4:45- 6:00 p.m.

    Groups 4-6 Early Registration

    6:45-8:15 p.m.

    Dinner and General Session for all Attendees with Faculty: Tips &Tricks

    Saturday, January 18, 2020

    6:15 – 7:15 a.m.

    Registration

    7:15– 11:45 a.m..

    Morning  Sessions

    11:45 a.m.– 12:30 p.m.

    Break

    12:30 – 5:00 p.m.

    Afternoon Sessions

    5:00 p.m.

    Course Adjourns

    Grand Hyatt DFW International Airport
    2337 South International Parkway
    Dallas, TX 75261
    United States

    What to Know Before You Go

    Airport Transfers

    The Grand Hyatt DFW is seamlessly integrated into Dallas Fort Worth Airport International Terminal D and accessible by complimentary transportation via Skylink or Terminal Link. If you did not check a bag with security, please take Skylink to Terminal D. Should you have to pick up your bag at baggage claim, please follow the signs to Terminal Link and proceed to board the shuttle towards Terminal D/Grand Hyatt DFW. Additional transportation information and directions. If you are driving, please contact the hotel for the most up-to-date parking rates.


    Parking

    • Enter Airport through Public Access to obtain a ticket.
    • Exit at Terminal D, follow signs to parking, this will require you to be in the far left of the three lanes.
    • Enter the parking garage and proceed to Level 3 and park in the Gate 22 area. Please avoid parking in the 2-hour parking.
    • If you park on another level, park in the Gate 22 area, again do not park in 2-hour parking. Take the elevator to Level 3.
    • Once on Level 3, take the walkway to the hotel entrance. You will see the Grand Hyatt sign above the revolving door.
    • Upon entering the terminal, take a right to the elevators. Take the elevator to the LL floor for conference level meetings, or the Lobby Level for conference suite meetings or to check in to the hotel.
    • Do not use the Toll Tag Entrance to the airport; the hotel cannot validate your parking if you do.
    • Do Not Park in 2-Hour Parking unless you will be parked for less than 2 hours.

    Meals

    Breakfast is not included with the course registration; however; a boxed lunch will be provided as well as dinner Friday, January 25. Time for meals is varied and limited, as well as dining options within the hotel. Please review your schedule carefully, and plan accordingly.

    Moka: Hotel's coffee shop with grab-and-go items. Open 5:30 am – 1:30 pm.

    The Grand Met Restaurant: Dine-in restaurant. Open 6:30 am - 2:00 pm and 5:30 pm - 10:30 pm.


    Dress

    You will be expected to dress as you would for the actual ABU oral board exam. Business attire is strongly advised. Attire for the dinner/ general session is business casual.


    Weather

    The approximate temperatures in Dallas during this time of year are a high of 60ºF and a low of 30ºF.

    The AUA recommends that you register for the course BEFORE making travel arrangements. Once the meeting capacity is reached, which may be prior to the early-bird date, the AUA is unable to guarantee a spot in the course.

    A peaceful oasis with state-of-the-art sophistication, the newly enhanced incomparable DFW airport hotel sets the bar for all others. Warm design elements and subdued lighting evoke a European boutique atmosphere. Seamlessly integrated into International Terminal D and accessible by SkyLink or Terminal Link, Grand Hyatt DFW provides a pampered experience for all. Slumber serenely in especially sound-proofed guestrooms featuring plush Hyatt Grand Beds™ and deluxe granite baths with separate shower and soaking tub. 

    To hold a reservation, a major credit card number must be provided.

    Room Rate: $245 single/double occupancy. To make your reservation, call 972-973-1234. Reference the American Urological Association Oral Board Review Course to receive the special group rate. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

    Cut-off Date: Friday, December 20, 2019 . Guest rooms may not be available at the AUA special rate after this date.

    Check-in: 3 p.m.
    Check-out: Noon

    Questions?

    Call 1-800-908-9414 or email registration@AUAnet.org.

    Travel

    Please note: When utilizing a navigation app, the Hotel recommends using the address for DFW Airport and then following the street signs to Grand Hyatt DFW in Terminal D on the departures level. 

    Grand Hyatt DFW, located inside Terminal D near Gate 22, is pleased to offer an 8,100 space covered "smart" parking garage. Convenient self-parking is complimentary for hotel guests. Please see our front desk personnel for a parking voucher upon check out or anytime you’re leaving the airport property. 

    Valet parking is also available for a fee. Grand Hyatt DFW's valet stand is located on the departures level, near gates D22-24. Please contact the hotel for the most up-to-date rates at 972-973-1234.

    Transportation: Located in Terminal D near Gate 22, there are no transportation costs to reach Grand Hyatt DFW from DFW Airport terminals. If coming from another terminal, travelers have several options:

    Skylink: For Ticketed passengers only with carry-on luggage, no checked luggage

    • DFW Airport's complimentary high-speed train
    • Located inside security
    • Continual service; trains arrive every few minutes
    • Follow signs to the Skylink, and take the train to Terminal D/Grand Hyatt
    • Exit Skylink and follow signs to Grand Hyatt

    Terminal Link: For all passengers - ticketed or un-ticketed, with or without luggage

    • DFW Airport's complimentary shuttle bus
    • Curbside on Arrivals/Luggage Claim level
    • Pickup every five minutes
    • If you have checked luggage, proceed to baggage claim
    • Follow signs outside to Terminal Link
    • Wait for Terminal D/Grand Hyatt Terminal Link Bus that will bring you to the hotel entrance

    Additional transportation information and directions. For more information on transportation options once checked in as a guest of Grand Hyatt DFW, please contact the on-site concierge at 972-973-1234.

    Education Council Disclosures

    PDF icon Education Council Disclosures

     

    AUA Office of Education Staff has nothing to disclose.

    Course Co-director(s)

    Elspeth McDougall, MD,FRCSC

    has no relevant financial relationships to disclose at this time.

    Andrew Peterson, MD,MPH

    has a financial relationship (Independent contractor) with American Medical Systems INC;.
    has a financial relationship (Other) with American Medical Systems INC;.
    has a financial relationship (Independent contractor) with American Medical Systems INC;.
    has a financial relationship (Other) with American Medical Systems INC;.
    Faculty(s)

    Edwin Jason Abel, MD, FACS

    has no relevant financial relationships to disclose at this time.

    Jordan Angell, MD, FACS

    has no relevant financial relationships to disclose at this time.

    Gopal Badlani, MD,FACS,FRCS

    has a financial relationship (Independent contractor) with Urology times;.
    has a financial relationship (Independent contractor) with Urology times;.
    has a financial relationship (Independent contractor) with Neotract;.
    has a financial relationship (Independent contractor) with Neotract;.
    has a financial relationship (Independent contractor) with Olympus corp;.
    has a financial relationship (Independent contractor) with Olympus corp;.
    has a financial relationship (Stock) with Lithotripsy group : Piedmont stone & physcian discovery;.
    has a financial relationship (Stock) with Lithotripsy group : Piedmont stone & physcian discovery;.

    Karen C. Baker, MD

    has no relevant financial relationships to disclose at this time.

    Sara Best, MD

    has a financial relationship (Independent contractor) with American Urological Association;.
    has a financial relationship (Independent contractor) with American Urological Association;.

    Benjamin Breyer, MD, MS

    has no relevant financial relationships to disclose at this time.

    Thomas Chi, MD,MBA

    has a financial relationship (Independent contractor) with Bard Medical;.
    has a financial relationship (Independent contractor) with Boston Scientific Corporation;.
    has a financial relationship (Independent contractor) with Bard Medical;.
    has a financial relationship (Independent contractor) with Boston Scientific Corporation;.

    Brian Eisner, MD

    has a financial relationship (Independent contractor) with Allena Pharmaceuticals;.
    has a financial relationship (Other Business Ownership) with Kalera Medical;.
    has a financial relationship (Independent contractor) with Sonomotion;.
    has a financial relationship (Other Business Ownership) with Kalera Medical;.
    has a financial relationship (Independent contractor) with Sonomotion;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Other Business Ownership) with Dr. Arnies LLC;.
    has a financial relationship (Other Business Ownership) with Dr. Arnies LLC;.
    has a financial relationship (Independent contractor) with Allena Pharmaceuticals;.

    Shubham Gupta, MD

    has no relevant financial relationships to disclose at this time.

    Vesna Ivancic, MD

    has no relevant financial relationships to disclose at this time.

    Stephen Jackman, MD

    has no relevant financial relationships to disclose at this time.

    Melissa Kaufman, MD, PHD, FACS

    has a financial relationship (Other) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Other) with Valencia Technologies;.
    has a financial relationship (Other) with Valencia Technologies;.
    has a financial relationship (Independent contractor) with Journal of Urology;.
    has a financial relationship (Other) with Cook Myosite;.
    has a financial relationship (Independent contractor) with Journal of Urology;.
    has a financial relationship (Other) with Cook Myosite;.
    has a financial relationship (Other) with Boston Scientific;.

    Michael Kennelly, MD

    has a financial relationship (Other) with NIH;.
    has a financial relationship (Other) with Ipsen;.
    has a financial relationship (Independent contractor) with EBT Medical;.
    has a financial relationship (Other) with FemPulse;.
    has a financial relationship (Other) with Allergan;.
    has a financial relationship (Independent contractor) with Allergan;.
    has a financial relationship (Independent contractor) with Taris;.
    has a financial relationship (Independent contractor) with Cogentix;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Independent contractor) with Astellas;.
    has a financial relationship (Independent contractor) with Axonics;.
    has a financial relationship (Independent contractor) with Coloplast;.
    has a financial relationship (Other) with Urovant;.
    has a financial relationship (Other) with Cook Myosite;.
    has a financial relationship (Other) with FemPulse;.
    has a financial relationship (Other) with Amphora Medical, Inc;.
    has a financial relationship (Independent contractor) with Allergan;.
    has a financial relationship (Independent contractor) with Advadel;.
    has a financial relationship (Independent contractor) with Cogentix;.
    has a financial relationship (Other) with Dignify Therapeutics;.
    has a financial relationship (Independent contractor) with Astellas;.
    has a financial relationship (Independent contractor) with SchwabCare;.
    has a financial relationship (Other) with Boston Scientific;.
    has a financial relationship (Other) with Urovant;.
    has a financial relationship (Independent contractor) with Urovant;.
    has a financial relationship (Other) with Ipsen;.
    has a financial relationship (Other) with Amphora Medical, Inc;.
    has a financial relationship (Other) with Amphora Medical;.
    has a financial relationship (Independent contractor) with Advadel;.
    has a financial relationship (Other) with EBT Medical;.
    has a financial relationship (Other) with Dignify Therapeutics;.
    has a financial relationship (Independent contractor) with Dignify Therapeutics;.
    has a financial relationship (Independent contractor) with SchwabCare;.
    has a financial relationship (Other) with Taris;.
    has a financial relationship (Other) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Urovant;.
    has a financial relationship (Other) with Axonics;.
    has a financial relationship (Other) with Cook Myosite;.
    has a financial relationship (Other) with Coloplast;.
    has a financial relationship (Other) with Amphora Medical;.
    has a financial relationship (Other) with NIH;.
    has a financial relationship (Other) with EBT Medical;.
    has a financial relationship (Independent contractor) with EBT Medical;.
    has a financial relationship (Independent contractor) with Dignify Therapeutics;.
    has a financial relationship (Other) with Allergan;.
    has a financial relationship (Other) with Taris;.
    has a financial relationship (Independent contractor) with Taris;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Axonics;.
    has a financial relationship (Independent contractor) with Axonics;.
    has a financial relationship (Other) with Coloplast;.
    has a financial relationship (Independent contractor) with Coloplast;.

    Kate Kraft, MD,FACS,FAAP

    has no relevant financial relationships to disclose at this time.

    John Lacy, MD

    has no relevant financial relationships to disclose at this time.

    Dolores Lamb, PHD

    has a financial relationship (Independent contractor) with Shanghai Andrology Soc and Shanghai General Hospital;.
    has a financial relationship (Independent contractor) with Shanghai Andrology Soc and Shanghai General Hospital;.
    has a financial relationship (Independent contractor) with Shanghai Andrology Soc and Shanghai General Hospital;.
    has a financial relationship (Independent contractor) with Shanghai Andrology Soc and Shanghai General Hospital;.
    has a financial relationship (Independent contractor) with American Board of Bioanalysts;.
    has a financial relationship (Independent contractor) with American Board of Bioanalysts;.
    has a financial relationship (Independent contractor) with Fui. Film Irvine Scientific Chicago IVF Seminar;.
    has a financial relationship (Independent contractor) with Fui. Film Irvine Scientific Chicago IVF Seminar;.

    Paul Lange, MD, FACS

    has no relevant financial relationships to disclose at this time.

    Wesley Mayer, MD

    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Astellas;.

    Sarah McAchran, MD, FACS

    has no relevant financial relationships to disclose at this time.

    Suzanne Merrill, MD, FACS

    has no relevant financial relationships to disclose at this time.

    Drogo Montague, MD

    has no relevant financial relationships to disclose at this time.

    Carl Olsson, MD, FACS

    has a financial relationship (Other) with National Cancer Institute;.
    has a financial relationship (Other Business Ownership) with Dianon;.
    has a financial relationship (Other) with Urotronic Robust III study;.
    has a financial relationship (Independent contractor) with American Urological Assn;.
    has a financial relationship (Other) with miR Scientific;.
    has a financial relationship (Other) with Urotronic Robust III study;.
    has a financial relationship (Independent contractor) with American Urological Assn;.
    has a financial relationship (Other) with Myriad Genetics Inc;.
    has a financial relationship (Stock) with exilixis;.
    has a financial relationship (Other) with Myriad Genetics Inc;.
    has a financial relationship (Stock) with exilixis;.
    has a financial relationship (Other) with Dendreon Pharmaceuticals, LLC;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with Dendreon Pharmaceuticals, LLC;.
    has a financial relationship (Other) with Astellas;.
    has a financial relationship (Other) with miR Scientific;.
    has a financial relationship (Other) with National Cancer Institute;.
    has a financial relationship (Other Business Ownership) with Dianon;.

    Michael Ost, MD

    has no relevant financial relationships to disclose at this time.

    Thomas Polascik, MD

    has a financial relationship (Stock) with Endocare;.
    has a financial relationship (Independent contractor) with Precision Biopsy;.
    has a financial relationship (Independent contractor) with Endocare;.
    has a financial relationship (Stock) with Endocare;.
    has a financial relationship (Independent contractor) with Endocare;.
    has a financial relationship (Independent contractor) with Precision Biopsy;.

    Sima Porten, MD, FACS, MPH

    has a financial relationship (Other) with Photocure;.
    has a financial relationship (Independent contractor) with Photocure;.
    has a financial relationship (Other) with Photocure;.
    has a financial relationship (Independent contractor) with Photocure;.

    Jay Raman, MD, FACS

    has a financial relationship (Other) with Urogen Pharma;.
    has a financial relationship (Stock) with American Kidney Stone Management;.
    has a financial relationship (Independent contractor) with Urogen Pharma;.
    has a financial relationship (Other) with Urogen Pharma;.
    has a financial relationship (Independent contractor) with Urogen Pharma;.
    has a financial relationship (Stock) with American Kidney Stone Management;.

    Art Rastinehad, DO

    has a financial relationship (Independent contractor) with NanoSpectra Biopsciences;.
    has a financial relationship (Other) with Philips, Inc;.
    has a financial relationship (Other) with NanoSpectra Biopsciences;.
    has a financial relationship (Other) with Philips, Inc;.
    has a financial relationship (Independent contractor) with NanoSpectra Biopsciences;.
    has a financial relationship (Other) with NanoSpectra Biopsciences;.

    Jerome Richie, MD

    has no relevant financial relationships to disclose at this time.

    Henry Rosevear, MD

    has no relevant financial relationships to disclose at this time.

    Jonathan Routh, MD

    has a financial relationship (Other) with NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES ;.
    has a financial relationship (Other) with NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES ;.

    Charles Scales, MD, FACS, MS

    has a financial relationship (Other) with National Cancer Institute;.
    has a financial relationship (Other) with National Cancer Institute;.
    has a financial relationship (Other) with Allena Pharmaceuticals;.
    has a financial relationship (Other) with Allena Pharmaceuticals;.
    has a financial relationship (Independent contractor) with Gilead;.
    has a financial relationship (Independent contractor) with Gilead;.
    has a financial relationship (Other) with Astra-Zeneca;.
    has a financial relationship (Other) with Astra-Zeneca;.

    Bruce Schlomer, MD

    has no relevant financial relationships to disclose at this time.

    J. Selph, MD

    has no relevant financial relationships to disclose at this time.

    Wade Sexton, MD

    has no relevant financial relationships to disclose at this time.

    Anand Shridharani, MD

    has no relevant financial relationships to disclose at this time.

    Ryan Smith, MD

    has a financial relationship (Other) with Aytu Biosciences;.
    has a financial relationship (Independent contractor) with Aytu Biosciences;.
    has a financial relationship (Other) with Aytu Biosciences;.
    has a financial relationship (Independent contractor) with Aytu Biosciences;.

    O. Westney, MD

    has a financial relationship (Employment) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.
    has a financial relationship (Employment) with Boston Scientific;.
    has a financial relationship (Independent contractor) with Boston Scientific;.

    Daniel Williams, MD

    has no relevant financial relationships to disclose at this time.

    ACCREDITATION: 

    The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    CREDIT DESIGNATION: 

    The American Urological Association designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    OTHER LEARNERS: 

    The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    EVIDENCE BASED CONTENT: 

    It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA DISCLOSURE POLICY: 

    All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

    RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

    All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

    The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


    AUA PARTICIPANT INFORMATION & POLICIES

    Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

    Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

    Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

    Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

    Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

     
    Status
    Price
    Title
    $2,245.00Included
    Please login or register to take this course.
    $2,245.00Included
    Please login or register to take this course.
    $150.00Included
    Please login or register to take this course.
    $299.00Included
    Please login or register to take this course.

    Price

    Price:
    $2,245.00
    Please login or register to take this course.

    Attendees must choose the Friday Program OR Saturday Program when registering. Can choose either/or, not both.

     

    AUA Members save 20%! For more information on membership benefits, visit www.AUAnet.org/Join

     

    Registration Fees

     

    Live Course 

    Early Bird Registration
    (on or before December 6, 2019)

    Live Course

    Standard Registration
    (On or after December 7, 2019)

    Oral Board Study Guide App*

    AUA Member$1495$1795$150
    AUA Non-Member$1865$2245

    *Discounted Pricing on the Oral Board Study Guide App Only For Course Registrants (Regularly $300) 

    Register on or before December 6th to save 25%!


    Cancellation Policy

     

    Live Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

    Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than to six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

    Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912.  Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

    AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before December 18, 2020. If AUA Education & Research cancels this course, notification will be sent by December 25, 2020.


    AUA Participant Information and Policies

     

    Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

    Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

    Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.